<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0002163'>Glandular dysplasia</z:mp> in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> may regress spontaneously but can also progress to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The human telomerase <z:chebi fb="40" ids="33697">RNA</z:chebi> template and the human telomerase reverse transcriptase enzyme which do not, of themselves, correlate strongly with telomerase activity, are too often overexpressed in Barrett's <z:mpath ids='MPATH_589'>dysplasia</z:mpath> to predict individual <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk </plain></SENT>
<SENT sid="2" pm="."><plain>This study relates telomerase activity, mucosal phenotype, and <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Biopsies (n = 256) from squamous esophagus, <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">columnar-lined esophagus</z:e> every 2 cm, esophago-gastric junction, gastric body, and antrum from 32 patients with long-segment <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> were evaluated by telomerase repeat assay protocol (TRAP) </plain></SENT>
<SENT sid="4" pm="."><plain>Three biopsies for histology (n = 794) were simultaneously taken at each anatomical level </plain></SENT>
<SENT sid="5" pm="."><plain>These and <z:hpo ids='HP_0000001'>all</z:hpo> prior and subsequent biopsies (n = 1917) were reviewed for mucosal phenotypes and <z:mpath ids='MPATH_589'>dysplasia</z:mpath> severity </plain></SENT>
<SENT sid="6" pm="."><plain>Intestinal-type Barrett's mucosa was present at <z:hpo ids='HP_0000001'>all</z:hpo> levels in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>At least one Barrett's biopsy was TRAP(+) in 22 of 32 patients </plain></SENT>
<SENT sid="8" pm="."><plain>TRAP positivity of intestinal-type Barrett's mucosa increased distally, possibly as a consequence of mucosal exposure to acid or <z:e sem="disease" ids="C0005403" disease_type="Disease or Syndrome" abbrv="">bile reflux</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Native gastric mucosa was rarely TRAP(+) (1/31 corpus, 2/32 antrum), whereas native squamous mucosa usually was TRAP(+) (31/32) </plain></SENT>
<SENT sid="10" pm="."><plain><z:mpath ids='MPATH_589'>Dysplasia</z:mpath> almost always involved intestinal-type Barrett's mucosa (85/87; P &lt;.00001), without evidence of proximal-distal zoning </plain></SENT>
<SENT sid="11" pm="."><plain>TRAP could be positive without <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and negative in extensive, even high-grade, <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="12" pm="."><plain>TRAP activity merits evaluation as a candidate biomarker for increased risk of persistent <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">cancer progression</z:e> in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
</text></document>